文献速递胸部肿瘤放疗放疗物理与技术

一项两机构前瞻性临床试验的期中分析:基于4DCT通气功能回避的放射治疗

Interim Analysis of a Two-Institution, Prospective Clinical Trial of 4DCT-Ventilation-based Functional Avoidance Radiation Therapy.
PubMed 文献 · Int J Radiat Oncol Biol Phys · 2018-10-18

该两机构2期前瞻性试验评估4DCT通气功能回避放疗的可行性、安全性和初步疗效,计划入组17例可评估患者后进行Simon两阶段无效性分析。功能肺V20为21.6%±9.5%,较标准计划降低3.2%(P<.01);≥2级和≥3级放射性肺炎发生率分别为17.6%(95%CI 3.8%-43.4%)和5.9%(95%CI 0.1%-28.7%)。基于17.6%的≥2级肺炎发生率,试验未达到无效性标准,继续入组。

要点

  • 功能回避计划使功能肺V20降至21.6%±9.5%,较标准计划降低3.2%(P<.01)。
  • ≥2级放射性肺炎发生率为17.6%(95%CI 3.8%-43.4%)。
  • 基于Simon两阶段设计,试验未达到无效性标准并继续入组。

核心结论

  • 功能回避在满足靶区和危及器官约束的同时降低了功能肺剂量。
  • 基于Simon两阶段设计和17.6%的≥2级肺炎发生率,试验达到无效性标准并继续入组。

研究设计与样本

  • 两机构、2期前瞻性临床试验,评估4DCT通气功能回避的可行性、安全性和初步疗效。
  • 采用Simon两阶段设计,计划在17例可评估患者后进行无效性分析。
  • 合格患者为处方剂量45至75 Gy的肺癌患者。
  • 使用Hounsfield单位技术和可压缩流图像配准算法由4DCT生成4DCT通气图像。
  • 为每例患者生成标准肺计划和功能回避计划,患者接受功能回避计划治疗并随访1年评估胸部毒性。

主要发现

  • 功能肺V20为21.6%±9.5%(均值±标准差),较标准非功能计划降低3.2%(P<.01)。
  • ≥2级放射性肺炎发生率为17.6%(95%CI 3.8%-43.4%)。
  • ≥3级放射性肺炎发生率为5.9%(95%CI 0.1%-28.7%)。

关键数值与推荐

  • 试验假设功能回避可将≥2级放射性肺炎发生率降至12%,而历史对照为25%。
  • 合格患者处方剂量为45至75 Gy。
  • 功能回避计划旨在降低功能肺剂量,同时满足靶区和正常组织约束。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Functional imaging has been proposed that uses 4DCT images to calculate 4DCT-based lung ventilation (4DCT-ventilation). We have started a 2-institution, phase 2 prospective trial evaluating the feasibility, safety, and preliminary efficacy of 4DCT-ventilation functional avoidance. The trial hypothesis is that the rate of grade ≥2 radiation pneumonitis could be reduced to 12% with functional avoidance, compared with a 25% rate of pneumonitis with a historical control. The trial employed a Simon 2-stage design with a planned futility analysis after 17 evaluable patients. The purpose of this work is to present the trial design and implementation, dosimetric data, and clinical results for the planned futility analysis. METHODS AND MATERIALS: Eligible patients were patients with lung cancer who were prescribed doses of 45 to 75 Gy. For each patient, the 4DCT data were used to generate a 4DCT-ventilation image using the Hounsfield unit technique along with a compressible flow-based image registration algorithm. Two intensity modulated radiation therapy treatment plans were generated: (1) a standard lung plan and (2) a functional avoidance treatment plan that aimed to reduce dose to functional lung while meeting target and normal tissue constraints. Patients were treated with the functional avoidance plan and evaluated for thoracic toxicity (presented as rate and 95% confidence intervals [CI]) with a 1-year follow-up. RESULTS: The V20 to functional lung was 21.6% ± 9.5% (mean ± standard deviation) with functional avoidance, representing a decrease of 3.2% (P < .01) relative to standard, nonfunctional treatment plans. The rates of grade ≥2 and grade ≥3 radiation pneumonitis were 17.6% (95% CI, 3.8%-43.4%) and 5.9% (95% CI, 0.1%-28.7%), respectively. CONCLUSIONS: Dosimetrically, functional avoidance achieved reduction in doses to functional lung while meeting target and organ at risk constraints. On the basis of Simon's 2-stage design and the 17.6% grade ≥2 pneumonitis rate, the trial met its futility criteria and has continued accrual.

来源:Int J Radiat Oncol Biol Phys,查看原文。版权归原作者所有。

引用

  1. Vinogradskiy Y, Rusthoven CG, Schubert L, et al. Interim Analysis of a Two-Institution, Prospective Clinical Trial of 4DCT-Ventilation-based Functional Avoidance Radiation Therapy. Int J Radiat Oncol Biol Phys. 2018. PMID: 30353873. doi:10.1016/j.ijrobp.2018.07.186

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。